Solo-GP Dr. Ling Wong (MIT, Harvard PhD; inventor of the first inhaled TB vaccine) invests $500K–$50M seed through growth, bringing scientific expertise, breakout-company established record and top-tier co-investor access. The firm continues to build its presence across the venture capital landscape.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Selective firm investing where it has an unfair advantage, running a company-creation platform with 22 EIRs and a 90+ C-suite council delivering market insights to healthcare, data+AI and cyber defense. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Series B investor (~$15M checks) acting as venture coaches—former Twitter, Google, and Facebook execs who avoid board seats and support founders build sales organizations and revenue operations. The firm continues to build its presence across the venture capital landscape.
Targets hard, capital‑intensive sustainability technologies other VCs avoid, bridging solutions from developed markets into China and developing countries (energy, food, health, environment) to build traction back into developed markets. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
A Los Angeles-based venture fund and startup studio where Spencer Rascoff directly incubates proptech and future-of-living nascent-stage companies, providing media-driven exposure, co-creation expertise, and public-market/SPAC experience. The firm continues to build its presence across the venture capital landscape.
Is dedicated to companies empowering informed, connected health consumers and building system-level resilience to improve outcomes, experiences, and lower healthcare costs. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Growth-stage investor in fintech/financial infrastructure and logistics/supply-chain foundational systems, providing strategic intelligence from former heads of state and national security leaders plus policy and compliance expertise. The firm continues to build its presence across the venture capital landscape.
